Cognitive Impairment Diagnosis and Management

Summary

Cognitive impairment encompasses a spectrum from subtle memory lapses to severe deficits that disrupt daily living. Diagnosis typically combines clinical history, standardised neuropsychological assessments and structural or functional neuroimaging. Emerging fluid biomarkers and advanced digital assessments promise earlier and more precise detection. Management strategies range from pharmacological agents—targeting cholinergic deficits or modulating amyloid and tau pathways—to non-pharmacological approaches such as cognitive training, physical exercise and dietary modification. Complementary therapies, including herbal formulations and mind–body interventions, are under investigation as adjuncts. A personalised care plan integrates risk-factor modification, symptom monitoring and regular reassessment, addressing both neurobiological changes and psychosocial needs. In a globally ageing population, scalable diagnostic tools and evidence-based interventions are critical to delaying progression, preserving independence and reducing societal burden.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Cognitive Impairment Diagnosis and Management publication trend

The graph below shows the total number of articles in cognitive impairment diagnosis and management across all publications each year (not limited to Nature Index journals).

Technical terms

Mild cognitive impairment (MCI): A syndrome characterised by objective decline in one or more cognitive domains beyond expected age-related changes, without significant interference in daily functioning.

Biomarker: A measurable indicator of a biological state or condition, used for diagnosis, prognosis or monitoring of disease.

Digital biomarker: Quantitative data collected through digital devices (eg, smartphones, wearables) reflecting physiological or behavioural patterns associated with health or disease.

Randomised controlled trial (RCT): An experimental study design in which participants are randomly assigned to intervention or control groups to assess the efficacy and safety of treatments.

References

  1. A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment. Alzheimer's & Dementia: Translational Research & Clinical Interventions (2023).
  2. Multidimensional digital biomarker phenotypes for mild cognitive impairment: considerations for early identification, diagnosis and monitoring. Frontiers in Digital Health (2024).
  3. Acupressure and Cognitive Training Can Improve Cognitive Functions of Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial. Frontiers in Psychology (2021).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.